REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Giotas, A., Agathocleous, A., Kalpadakis, C., Akay, O., Atalar, S., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, C., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

P1179: EFFECTIVENESS OF CENTRAL NERVOUS SYSTEM PROPHYLAXIS STRATEGIES IN DIFFUSE LARGE B‐CELL LYMPHOMA von Eraslan, F. Z., Toptas, T., Tuglular, T., Atagunduz, I.

Volltext

RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadakis, C., Akay, O. M., Atalar, A. C., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey von Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., Toptas, T., Firatli Tuglular, T., Tekgunduz, E., Kaya, A., Tastemir, N., Arat, M., Pepedil Tanrikulu, F., Ozkocaman, V., Abali, H., Turgut, M., Kaynar, L., Karadogan, I., Ozbalak, M., Dogu, M., Kabukcu Hacioglu, S., Yildirim, R., Barista, I., Kurt Yuksel, M., Sonmez, M.

Volltext

P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A REAL‐WORLD DATA FROM TURKEY von Dal, M. S., Uncu Ulu, B., Uzay, A., Akay, O. M., Besisik, S., Yenerel, M. N., Celik, S., Kaynar, L., Yucel, O. K., Deveci, B., Sonmez, M., Mehtap, O., Bekoz, H. S., Sunu, C., Salim, O., Ulas, T., Karti, S., Altuntas, F., Ferhanoglu, B., Firatli Tuglular, T.

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience von Beköz, H., Karadurmuş, N., Paydaş, S., Türker, A., Toptaş, T., Fıratlı Tuğlular, T., Sönmez, M., Gülbaş, Z., Tekgündüz, E., Kaya, A.H., Özbalak, M., Taştemir, N., Kaynar, L., Yıldırım, R., Karadoğan, I., Arat, M., Pepedil Tanrıkulu, F., Özkocaman, V., Abalı, H., Turgut, M., Kurt Yüksel, M., Özcan, M., Doğu, M.H., Kabukçu Hacıoğlu, S., Barışta, I., Demirkaya, M., Köseoğlu, F.D., Toprak, S.K., Yılmaz, M., Demirkürek, H.C., Demirkol, O., Ferhanoğlu, B.

Volltext

893 RATE AND TYPE OF LIVER INJURY AFTER BMT MAY DEPEND ON THE CONDITIONING REGIMEN IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES von Alahdab, Y, Aktas, B, Kaygusuz, I, Gunduz, F, Kedrah, A, Cetiner, M, Tuglular, T, Bayik, M, Ozdogan, O, Tozun, N

Volltext

P1229: RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

PB1953 QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA von Toptas, T., Bostan, H., Kut, K., Pepedil Tanrikulu, F., Yilmaz, F., Atagunduz, I., Tuglular, T.

Volltext

Thrombophilia and inflammatory bowel disease: does factor V mutation have a role? von Hamzaoglu Över, Hülya, Ülgen, Sertag, Tuglular, Tülin, Tezel, Ahmet, Avsar, Erol, Geyik, Göksel, Bangui, Senem, Sayhan, Nur, Ulusoy, Nefise, Kalayci, Cem, Tözün, Nurdan

Volltext

PB1947 COMPARISON OF EFFICACY AND SIDE EFFECTS OF SECONDLINE DASATINIB AND NILOTINIB THERAPIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE RESISTANT OR INTOLERANT TO IMATINIB von Kaygusuz Atagunduz, I., Gecgel Arikan, F., Memis, T., Toptas, T., Yilmaz, F., Ipek, Y., Elibol, T., Tuglular, T.

Volltext

PB2235 SYMPTOM BURDEN AND SPLEEN SIZE RESPONSE WITH RUXOLUTINIB IN A REAL‐LIFE TURKISH COHORT von Tuglular, T., Arikan, F., Ercan, T., Elibol, T., Okcu, D., Ipek, Y., Ozgumus, T., Sezgin, A., Yilmaz, F., Atagunduz, I., Toptas, T.

Volltext

Post-Authorization Safety of Lenalidomide + Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Turkey von Fıratlı Tuğlular, T, Pehlivan, M, Sarı, H. İ, Ayyıldız, M.O, Saydam, G, Sönmez, M, Kalayoğlu Beşışık, S, Özgür, G, Gürkan, E, Kaynar, L, Ali, R, Özet, G, Demirkan, F, Öngören, S, Özdoğu, H, Gündüz, E, Naci Tiftik, E, Salim, O, Turgut, M, Hacıhanefioğlu, A, Barbaros Üre, U, Özdemir, E, Altuntaş, F, Şimşek, D, Ulu, N, Beksaç, M

Volltext

Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate von Kaygusuz Atagunduz, I, Toptas, T, Deniz, R, Kara, O, Eser, A, Sezgin, A, Ozgumus, T, Gecgel, F, Firatli Tuglular, T

Volltext

PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI‐CENTER EXPERIENCE IN TURKEY von Ferhanoglu, B., Ozbalak, M., Bekoz, H., Karadurmus, N., Paydas, S., Turker, A., Toptas, T., Tuglular, T. Firatli, Sonmez, M., Gulbas, Z., Demir, N., Kaynar, L., Yildirim, R., Karadogan, I., Arat, M., Tanrikulu, F. Pepedil, Ozkocaman, V., Abali, H., Turgut, M., Yuksel, M. Kurt, Ozcan, M., Hacioglu, S. Kabukcu, Barista, I., Demirkaya, M., Atilla, F.D., Toprak, S.K., Yilmaz, M.

Volltext

Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups von Beksac, Meral, Waage, Anders, Bringhen, Sara, Kristinsson, Sigurdur Y., Sucak, Gülsan Türköz, Gimsing, Peter, Lupparelli, Giulia, Fıratlı-Tuğlular, Tulin, Juliusson, Gunnar, Turesson, Ingemar, Palumbo, Antonio

Volltext

215 AZACYTIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA von Tuglular, T. Firatli, Tanrikulu, F. Pepedil, Atagunduz, I. Kaygusuz, Kara, O, Sezgin, A, Ozgumus, T, Eser, A, Toptas, T

Volltext

Nivolumab for relapsed or refractory H odgkin lymphoma: Experience in T urkey von Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., Toptas, T., Firatli Tuglular, T., Tekgunduz, E., Kaya, A., Tastemir, N., Arat, M., Pepedil Tanrikulu, F., Ozkocaman, V., Abali, H., Turgut, M., Kaynar, L., Karadogan, I., Ozbalak, M., Dogu, M., Kabukcu Hacioglu, S., Yildirim, R., Barista, I., Kurt Yuksel, M., Sonmez, M.

Volltext

Event-Based Input Validation Using Design-by-Contract Patterns von Tuglular, T., Muftuoglu, C.A., Belli, F., Linschulte, M.

Volltext

Efficacy of high‐dose methylprednisolone as a first‐line therapy in adult patients with idiopathic thrombocytopenic purpura von Alpdogan, Önder, Budak‐Alpdogan, Tülin, Ratip, Siret, Firatli‐Tuglular, Tülin, Tanriverdi, Serpil, Karti, Sami, Bayik, Mahmut, Akoglu, Tevfik

Volltext